Published in PLoS One on July 18, 2013
Nucleolin interacts with the dengue virus capsid protein and plays a role in formation of infectious virus particles. J Virol (2013) 0.90
Protection of a single dose west nile virus recombinant subviral particle vaccine against lineage 1 or 2 strains and analysis of the cross-reactivity with Usutu virus. PLoS One (2014) 0.83
The Role of Deoxycytidine Kinase (dCK) in Radiation-Induced Cell Death. Int J Mol Sci (2016) 0.78
Amino acid substitutions in the non-structural proteins 4A or 4B modulate the induction of autophagy in West Nile virus infected cells independently of the activation of the unfolded protein response. Front Microbiol (2015) 0.78
Inhibition of West Nile Virus Multiplication in Cell Culture by Anti-Parkinsonian Drugs. Front Microbiol (2016) 0.76
Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol (2001) 66.87
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science (1999) 18.55
Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol (2000) 13.34
A structural perspective of the flavivirus life cycle. Nat Rev Microbiol (2005) 5.02
B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol (2003) 4.87
T-Coffee: a web server for the multiple sequence alignment of protein and RNA sequences using structural information and homology extension. Nucleic Acids Res (2011) 4.00
Structure of the immature dengue virus at low pH primes proteolytic maturation. Science (2008) 3.86
West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annu Rev Med (2006) 3.68
Structures of immature flavivirus particles. EMBO J (2003) 3.62
PONDR-FIT: a meta-predictor of intrinsically disordered amino acids. Biochim Biophys Acta (2010) 3.62
Structure of West Nile virus. Science (2003) 3.48
A global perspective on the epidemiology of West Nile virus. Annu Rev Entomol (2008) 3.42
The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science (2008) 3.26
The molecular biology of West Nile Virus: a new invader of the western hemisphere. Annu Rev Microbiol (2002) 3.22
Infectious cDNA clone of the epidemic west nile virus from New York City. J Virol (2002) 3.21
A single positively selected West Nile viral mutation confers increased virogenesis in American crows. Nat Genet (2007) 3.02
Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively. J Virol (2001) 2.81
West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection. J Virol (2006) 2.79
CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol (2003) 2.69
Globalization, land use, and the invasion of West Nile virus. Science (2011) 2.63
Crystal structure of the West Nile virus envelope glycoprotein. J Virol (2006) 2.61
Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog (2009) 2.52
The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein. Virology (1992) 2.48
Nucleocapsid-glycoprotein interactions required for assembly of alphaviruses. J Virol (1994) 2.47
Rab 5 is required for the cellular entry of dengue and West Nile viruses. J Virol (2007) 2.12
Processing of viral glycoproteins by the subtilisin-like endoprotease furin and its inhibition by specific peptidylchloroalkylketones. Biochimie (1994) 2.07
The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex. J Virol (2010) 2.06
West Nile virus core protein; tetramer structure and ribbon formation. Structure (2004) 2.04
Immature dengue virus: a veiled pathogen? PLoS Pathog (2010) 2.04
Kinetics of endosome acidification detected by mutant and wild-type Semliki Forest virus. EMBO J (1986) 2.02
Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization. PLoS Pathog (2008) 2.00
N-linked glycosylation of west nile virus envelope proteins influences particle assembly and infectivity. J Virol (2005) 2.00
Variant influenza virus hemagglutinin that induces fusion at elevated pH. J Virol (1986) 2.00
Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody. EMBO J (2009) 1.85
Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles. Proc Natl Acad Sci U S A (1991) 1.79
Estimated cumulative incidence of West Nile virus infection in US adults, 1999-2010. Epidemiol Infect (2012) 1.78
Structure of immature West Nile virus. J Virol (2007) 1.77
Dealing with low pH: entry and exit of alphaviruses and flaviviruses. Trends Microbiol (2009) 1.60
Changing patterns of West Nile virus transmission: altered vector competence and host susceptibility. Vet Res (2009) 1.59
Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH. Virology (1993) 1.56
A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice. Virology (2006) 1.54
RNA binding properties of core protein of the flavivirus Kunjin. Arch Virol (1996) 1.47
Inhibitors of V-ATPases: old and new players. J Exp Biol (2009) 1.43
Association of the pr peptides with dengue virus at acidic pH blocks membrane fusion. J Virol (2009) 1.43
Evidence for a genetic and physical interaction between nonstructural proteins NS1 and NS4B that modulates replication of West Nile virus. J Virol (2012) 1.43
A therapeutic antibody against west nile virus neutralizes infection by blocking fusion within endosomes. PLoS Pathog (2009) 1.41
West Nile virus-induced neuroinflammation: glial infection and capsid protein-mediated neurovirulence. J Virol (2007) 1.31
Maturation of flaviviruses starts from one or more icosahedrally independent nucleation centres. EMBO Rep (2011) 1.31
The uncoating and infectivity of the flavivirus West Nile on interaction with cells: effects of pH and ammonium chloride. J Gen Virol (1986) 1.31
Association between the pH-dependent conformational change of West Nile flavivirus E protein and virus-mediated membrane fusion. J Gen Virol (1988) 1.28
Progress on the development of therapeutics against West Nile virus. Antiviral Res (2009) 1.26
Capturing a flavivirus pre-fusion intermediate. PLoS Pathog (2009) 1.24
RNA chaperoning and intrinsic disorder in the core proteins of Flaviviridae. Nucleic Acids Res (2007) 1.24
West Nile virus capsid protein induces p53-mediated apoptosis via the sequestration of HDM2 to the nucleolus. Cell Microbiol (2007) 1.18
Characterization of the functional requirements of West Nile virus membrane fusion. J Gen Virol (2009) 1.17
West Nile virus replication requires fatty acid synthesis but is independent on phosphatidylinositol-4-phosphate lipids. PLoS One (2011) 1.15
Recent advances in the molecular biology of west nile virus. Curr Mol Med (2005) 1.12
Flavivirus cell entry and membrane fusion. Viruses (2011) 1.08
Jab1 mediates cytoplasmic localization and degradation of West Nile virus capsid protein. J Biol Chem (2006) 1.06
West nile virus capsid degradation of claudin proteins disrupts epithelial barrier function. J Virol (2009) 1.03
Molecular mechanisms involved in the early steps of flavivirus cell entry. Microbes Infect (2010) 1.00
prM-antibody renders immature West Nile virus infectious in vivo. J Gen Virol (2011) 0.98
Acid-dependent viral entry. Virus Res (2012) 0.98
Molecular mechanisms of flavivirus membrane fusion. Amino Acids (2009) 0.97
Pregnancy increases the risk of mortality in West Nile virus-infected mice. J Gen Virol (2007) 0.96
MKRN1 induces degradation of West Nile virus capsid protein by functioning as an E3 ligase. J Virol (2010) 0.95
Uncoupling cis-Acting RNA elements from coding sequences revealed a requirement of the N-terminal region of dengue virus capsid protein in virus particle formation. J Virol (2011) 0.95
West Nile virus: A re-emerging pathogen revisited. World J Virol (2012) 0.94
Interactions between the West Nile virus capsid protein and the host cell-encoded phosphatase inhibitor, I2PP2A. Cell Microbiol (2007) 0.93
West Nile virus (WNV) transmission routes in the murine model: intrauterine, by breastfeeding and after cannibal ingestion. Virus Res (2010) 0.93
A West Nile virus mutant with increased resistance to acid-induced inactivation. J Gen Virol (2011) 0.92
The infectivity of prM-containing partially mature West Nile virus does not require the activity of cellular furin-like proteases. J Virol (2011) 0.92
Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease. Vaccine (2011) 0.91
The capsid-binding nucleolar helicase DDX56 is important for infectivity of West Nile virus. J Virol (2011) 0.90
Interactions of the cytoplasmic domain of Sindbis virus E2 with nucleocapsid cores promote alphavirus budding. J Virol (2011) 0.90
Acid-induced movements in the glycoprotein shell of an alphavirus turn the spikes into membrane fusion mode. EMBO J (2002) 0.90
Mutating conserved cysteines in the alphavirus e2 glycoprotein causes virus-specific assembly defects. J Virol (2012) 0.89
A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid lability and confer resistance to acid-dependent uncoating inhibition. J Virol (2010) 0.88
Identification of a conserved JEV serocomplex B-cell epitope by screening a phage-display peptide library with a mAb generated against West Nile virus capsid protein. Virol J (2011) 0.87
Human Sec3 protein is a novel transcriptional and translational repressor of flavivirus. Cell Microbiol (2009) 0.86
Hsp70 functions as a negative regulator of West Nile virus capsid protein through direct interaction. Biochem Biophys Res Commun (2006) 0.84
A single M protein mutation affects the acid inactivation threshold and growth kinetics of a chimeric flavivirus. Virology (2007) 0.84
Specific interaction of capsid protein and importin-alpha/beta influences West Nile virus production. Biochem Biophys Res Commun (2009) 0.83
Core protein-mediated 5'-3' annealing of the West Nile virus genomic RNA in vitro. Virus Res (2012) 0.82
Weak-base amines inhibit the anterograde-to-retrograde conversion of axonally transported vesicles in nerve terminals. J Neurocytol (1991) 0.78
2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature (2010) 3.49
Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. J Virol (2010) 3.10
Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins. J Virol (2005) 3.08
West Nile virus 5'-cap structure is formed by sequential guanine N-7 and ribose 2'-O methylations by nonstructural protein 5. J Virol (2006) 3.07
Structure and function of flavivirus NS5 methyltransferase. J Virol (2007) 2.93
A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity. Cell Host Microbe (2008) 2.93
NS5 of dengue virus mediates STAT2 binding and degradation. J Virol (2009) 2.42
The host response to West Nile Virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway. J Virol (2004) 2.37
West Nile virus. Lancet Neurol (2007) 2.26
An adenosine nucleoside inhibitor of dengue virus. Proc Natl Acad Sci U S A (2009) 2.20
Strategies for development of Dengue virus inhibitors. Antiviral Res (2010) 2.11
The structural basis for serotype-specific neutralization of dengue virus by a human antibody. Sci Transl Med (2012) 1.95
Ten years of dengue drug discovery: progress and prospects. Antiviral Res (2013) 1.84
Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication. J Virol (2005) 1.75
High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery. Antimicrob Agents Chemother (2005) 1.73
Triaryl pyrazoline compound inhibits flavivirus RNA replication. Antimicrob Agents Chemother (2006) 1.72
The West Nile virus mutant spectrum is host-dependant and a determinant of mortality in mice. Virology (2006) 1.72
Immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and from flavivirus vaccination. J Clin Microbiol (2003) 1.65
Discovery of 4-benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): a novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions. J Med Chem (2003) 1.57
West Nile virus infection of Drosophila melanogaster induces a protective RNAi response. Virology (2008) 1.56
Interaction between the cellular protein eEF1A and the 3'-terminal stem-loop of West Nile virus genomic RNA facilitates viral minus-strand RNA synthesis. J Virol (2007) 1.56
RNA structures required for production of subgenomic flavivirus RNA. J Virol (2010) 1.52
Distinct RNA elements confer specificity to flavivirus RNA cap methylation events. J Virol (2007) 1.48
Role of the mutant spectrum in adaptation and replication of West Nile virus. J Gen Virol (2007) 1.46
Tetracycline-inducible packaging cell line for production of flavivirus replicon particles. J Virol (2004) 1.44
West Nile virus methyltransferase catalyzes two methylations of the viral RNA cap through a substrate-repositioning mechanism. J Virol (2008) 1.44
The flavivirus-conserved penta-nucleotide in the 3' stem-loop of the West Nile virus genome requires a specific sequence and structure for RNA synthesis, but not for viral translation. Virology (2005) 1.43
Small molecule inhibitors that selectively block dengue virus methyltransferase. J Biol Chem (2010) 1.40
A mouse cell-adapted NS4B mutation attenuates West Nile virus RNA synthesis. Virology (2006) 1.38
West Nile virus genome cyclization and RNA replication require two pairs of long-distance RNA interactions. Virology (2008) 1.37
Structure and function of the 3' terminal six nucleotides of the west nile virus genome in viral replication. J Virol (2004) 1.33
2'-O methylation of internal adenosine by flavivirus NS5 methyltransferase. PLoS Pathog (2012) 1.32
Flavivirus methyltransferase: a novel antiviral target. Antiviral Res (2008) 1.31
Inhibition of dengue virus by targeting viral NS4B protein. J Virol (2011) 1.31
Keratinocytes are cell targets of West Nile virus in vivo. J Virol (2011) 1.29
Genetic diversity and purifying selection in West Nile virus populations are maintained during host switching. Virology (2008) 1.29
Functional analysis of two cavities in flavivirus NS5 polymerase. J Biol Chem (2011) 1.28
Inhibition of dengue virus polymerase by blocking of the RNA tunnel. J Virol (2010) 1.28
Potential high-throughput assay for screening inhibitors of West Nile virus replication. J Virol (2003) 1.25
Biochemical and genetic characterization of dengue virus methyltransferase. Virology (2010) 1.21
Terminal structures of West Nile virus genomic RNA and their interactions with viral NS5 protein. Virology (2008) 1.20
Development and characterization of a stable luciferase dengue virus for high-throughput screening. Antiviral Res (2011) 1.20
Population variation of West Nile virus confers a host-specific fitness benefit in mosquitoes. Virology (2010) 1.20
Identification of compounds with anti-West Nile Virus activity. J Med Chem (2006) 1.19
Exclusion of West Nile virus superinfection through RNA replication. J Virol (2009) 1.19
Stimulation of hepatitis C virus (HCV) nonstructural protein 3 (NS3) helicase activity by the NS3 protease domain and by HCV RNA-dependent RNA polymerase. J Virol (2005) 1.18
A single amino acid in nonstructural protein NS4B confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis. J Virol (2011) 1.17
Membrane topology and function of dengue virus NS2A protein. J Virol (2013) 1.16
A small molecule fusion inhibitor of dengue virus. Antiviral Res (2009) 1.16
In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus. Antimicrob Agents Chemother (2007) 1.15
West Nile virus experimental evolution in vivo and the trade-off hypothesis. PLoS Pathog (2011) 1.15
West Nile virus replication requires fatty acid synthesis but is independent on phosphatidylinositol-4-phosphate lipids. PLoS One (2011) 1.15
Zika Virus: Diagnosis, Therapeutics, and Vaccine. ACS Infect Dis (2016) 1.15
Crystal structure of enterovirus 71 RNA-dependent RNA polymerase complexed with its protein primer VPg: implication for a trans mechanism of VPg uridylylation. J Virol (2013) 1.14
Characterization of dengue virus resistance to brequinar in cell culture. Antimicrob Agents Chemother (2010) 1.13
Inhibition of dengue virus through suppression of host pyrimidine biosynthesis. J Virol (2011) 1.13
Rational design of a flavivirus vaccine by abolishing viral RNA 2'-O methylation. J Virol (2013) 1.12
Antiviral effect of interferon lambda against West Nile virus. Antiviral Res (2009) 1.12
Rational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaques. PLoS Pathog (2013) 1.11
A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor. Virology (2008) 1.11
Survey of bovine enterovirus in biological and environmental samples by a highly sensitive real-time reverse transcription-PCR. Appl Environ Microbiol (2005) 1.11
Enterovirus 71 VPg uridylation uses a two-molecular mechanism of 3D polymerase. J Virol (2012) 1.10
Genetic interactions among the West Nile virus methyltransferase, the RNA-dependent RNA polymerase, and the 5' stem-loop of genomic RNA. J Virol (2008) 1.09
Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo. Antiviral Res (2010) 1.09
Recent advances in flavivirus antiviral drug discovery and vaccine development. Recent Pat Antiinfect Drug Discov (2006) 1.04
U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication. Antiviral Res (2011) 1.04
Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein. Antimicrob Agents Chemother (2009) 1.03
Viral pathogenesis in mice is similar for West Nile virus derived from mosquito and mammalian cells. Virology (2010) 1.03
Separate molecules of West Nile virus methyltransferase can independently catalyze the N7 and 2'-O methylations of viral RNA cap. Virology (2008) 1.03
A crystal structure of the dengue virus non-structural protein 5 (NS5) polymerase delineates interdomain amino acid residues that enhance its thermostability and de novo initiation activities. J Biol Chem (2013) 1.03
A fluorescence-based alkaline phosphatase-coupled polymerase assay for identification of inhibitors of dengue virus RNA-dependent RNA polymerase. J Biomol Screen (2011) 1.01
Identification and characterization of inhibitors of West Nile virus. Antiviral Res (2009) 1.00
Structural and functional analyses of a conserved hydrophobic pocket of flavivirus methyltransferase. J Biol Chem (2010) 1.00
West Nile virus envelope protein glycosylation is required for efficient viral transmission by Culex vectors. Virology (2009) 1.00
Structural biology of dengue virus enzymes: towards rational design of therapeutics. Antiviral Res (2012) 0.98
Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C. J Gen Virol (2005) 0.98
Acid-dependent viral entry. Virus Res (2012) 0.98
The 5' and 3' downstream AUG region elements are required for mosquito-borne flavivirus RNA replication. J Virol (2010) 0.98
Internally deleted WNV genomes isolated from exotic birds in New Mexico: function in cells, mosquitoes, and mice. Virology (2012) 0.98
Conformational flexibility of the Dengue virus RNA-dependent RNA polymerase revealed by a complex with an inhibitor. J Virol (2013) 0.97
Higher catalytic efficiency of N-7-methylation is responsible for processive N-7 and 2'-O methyltransferase activity in dengue virus. Virology (2010) 0.97
Flavivirus RNA cap methyltransferase: structure, function, and inhibition. Front Biol (Beijing) (2010) 0.97
Serological immunoassay for detection of hepatitis E virus on the basis of genotype 3 open reading frame 2 recombinant proteins produced in Trichoplusia ni larvae. J Clin Microbiol (2009) 0.97
Crystal structure of the dengue virus methyltransferase bound to a 5'-capped octameric RNA. PLoS One (2010) 0.96
Inhibition of dengue virus RNA synthesis by an adenosine nucleoside. Antimicrob Agents Chemother (2010) 0.96
Flavivirus RNA methylation. J Gen Virol (2014) 0.96
Pregnancy increases the risk of mortality in West Nile virus-infected mice. J Gen Virol (2007) 0.96
N-sulfonylanthranilic acid derivatives as allosteric inhibitors of dengue viral RNA-dependent RNA polymerase. J Med Chem (2009) 0.95
A translation inhibitor that suppresses dengue virus in vitro and in vivo. Antimicrob Agents Chemother (2011) 0.95
Dimerization of flavivirus NS4B protein. J Virol (2014) 0.95
Outbreak of nosocomial hepatitis C virus infection resolved by genetic analysis of HCV RNA. J Clin Microbiol (2002) 0.94
West Nile virus: A re-emerging pathogen revisited. World J Virol (2012) 0.94
NMR analysis of a novel enzymatically active unlinked dengue NS2B-NS3 protease complex. J Biol Chem (2013) 0.93
A West Nile virus mutant with increased resistance to acid-induced inactivation. J Gen Virol (2011) 0.92